Treatment-refractory schizophrenia.

P. F. Buckley; L. D. Wiggins; S. Sebastian; B. Singer

doi:10.1007/s11920-996-0033-z

Treatment-refractory schizophrenia.

P. F. Buckley, L. D. Wiggins, S. Sebastian, B. Singer

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Treatment-refractory schizophrenia is common. Refinements in pharmacologic and psychosocial treatments of schizophrenia offer the expectation of superior outcomes for this disadvantaged patient group. This article critically reviews those articles that were published during the year 2000 that address this treatment-refractory population.

Original language	English (US)
Pages (from-to)	393-400
Number of pages	8
Journal	Current psychiatry reports
Volume	3
Issue number	5
DOIs	https://doi.org/10.1007/s11920-996-0033-z
State	Published - Oct 2001

ASJC Scopus subject areas

Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s11920-996-0033-z

Cite this

@article{ada52014f2534f1aadaf73c557a5114a,

title = "Treatment-refractory schizophrenia.",

abstract = "Treatment-refractory schizophrenia is common. Refinements in pharmacologic and psychosocial treatments of schizophrenia offer the expectation of superior outcomes for this disadvantaged patient group. This article critically reviews those articles that were published during the year 2000 that address this treatment-refractory population.",

author = "Buckley, {P. F.} and Wiggins, {L. D.} and S. Sebastian and B. Singer",

year = "2001",

month = oct,

doi = "10.1007/s11920-996-0033-z",

language = "English (US)",

volume = "3",

pages = "393--400",

journal = "Current psychiatry reports",

issn = "1523-3812",

publisher = "Current Science, Inc.",

number = "5",

}

TY - JOUR

T1 - Treatment-refractory schizophrenia.

AU - Buckley, P. F.

AU - Wiggins, L. D.

AU - Sebastian, S.

AU - Singer, B.

PY - 2001/10

Y1 - 2001/10

N2 - Treatment-refractory schizophrenia is common. Refinements in pharmacologic and psychosocial treatments of schizophrenia offer the expectation of superior outcomes for this disadvantaged patient group. This article critically reviews those articles that were published during the year 2000 that address this treatment-refractory population.

AB - Treatment-refractory schizophrenia is common. Refinements in pharmacologic and psychosocial treatments of schizophrenia offer the expectation of superior outcomes for this disadvantaged patient group. This article critically reviews those articles that were published during the year 2000 that address this treatment-refractory population.

UR - http://www.scopus.com/inward/record.url?scp=0344240649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0344240649&partnerID=8YFLogxK

U2 - 10.1007/s11920-996-0033-z

DO - 10.1007/s11920-996-0033-z

M3 - Review article

C2 - 11559476

AN - SCOPUS:0344240649

SN - 1523-3812

VL - 3

SP - 393

EP - 400

JO - Current psychiatry reports

JF - Current psychiatry reports

IS - 5

ER -

Treatment-refractory schizophrenia.

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this